Biochip Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
MARKET OVERVIEW
A growing need to reduce turnaround time and miniaturize biological and clinical tests used for research & diagnosis has increased demand for biochip and bio-array techniques. Biochips have applications ranging from disease marker identification to accelerated drug development, including a number of research applications in fields of genomics, genotyping, and proteomics. This chip can performs a thousands of biochemical reactions in few seconds. Simultaneous and specific profiling of biological markers is a major application of biochips. In addition, they are also critical components in studies investigating multiple parameters simultaneously.
MARKET SCOPE
The "Global Biochip Market Analysis to 2031" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Biochip market with detailed market segmentation by type and end user and geography. The report provides key statistics on the market status of the leading Biochip market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
Based on type, the global Biochip market is segmented into DNA chips, protein chips, lab-on-a-chip, other Arrays.
Based on end user, the market is categorised into hospitals and diagnostics centers, academic and research institutes, biotechnology and pharmaceutical companies.
MARKET DYNAMICS
Drivers
- Increased adoption in various applications in the field of genomics, drug discovery, and proteomics.
- The development of targeted and personalized medicines for the treatment of cancer.
- Technological advancements in biochips.
- Increase in expenditure on the clinical research.
Restraints-
Expensive technology along with need of specific tools such as robotics and bioinformatics.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Biochip market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Biochip market in these regions.
IMPACT OF COVID-19 ON BIOCHIP MARKET
With the outbreak of COVID-19, the market is expected to have a net positive impact on the lab-on-a-chip and microarray market. The global pandemic has increased the focus on the development of less time-consuming diagnostic kits along with the increased use of lab-on-a-chip and microarray techniques in pharmaceutical R&D, which is likely to have a positive effect on the market. Recently, one of the Singapore-based molecular diagnostics manufacturers, Veredus Laboratories in February 2021 has announced the commercial availability of their portable lab-on-chip diagnostic tool for the detection and differentiation 2021-nCoV, SARS-CoV, and MERS-CoV.
Mrinal Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any. 
Have a question?
Speak to Analyst
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Biochip market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Biochip market in these regions.
IMPACT OF COVID-19 ON BIOCHIP MARKET
With the outbreak of COVID-19, the market is expected to have a net positive impact on the lab-on-a-chip and microarray market. The global pandemic has increased the focus on the development of less time-consuming diagnostic kits along with the increased use of lab-on-a-chip and microarray techniques in pharmaceutical R&D, which is likely to have a positive effect on the market. Recently, one of the Singapore-based molecular diagnostics manufacturers, Veredus Laboratories in February 2021 has announced the commercial availability of their portable lab-on-chip diagnostic tool for the detection and differentiation 2021-nCoV, SARS-CoV, and MERS-CoV.
MARKET PLAYERS
The report covers key developments in the Biochip market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Biochip market are anticipated to lucrative growth opportunities in the future with the rising demand for Biochip in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Biochip market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Abbott Laboratories
- Agilent Technologies, Inc.
- PerkinElmer Inc.
- Fluidigm Corporation
- Illumina, Inc.
- GE Healthcare
- Bio-Rad Laboratories Inc.
- Cepheid Inc.
- Thermo Fisher Scientific, Inc.
- F. Hoffmann-La Roche AG
- Sigma-Aldrich Corporation
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Biochip Market - By Type
1.3.2 Biochip Market - By End User
1.3.3 Biochip Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BIOCHIP MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BIOCHIP MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BIOCHIP MARKET - GLOBAL MARKET ANALYSIS
6.1. BIOCHIP - GLOBAL MARKET OVERVIEW
6.2. BIOCHIP - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. BIOCHIP MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. DNA CHIPS
7.3.1. Overview
7.3.2. DNA Chips Market Forecast and Analysis
7.4. PROTEIN CHIPS
7.4.1. Overview
7.4.2. Protein Chips Market Forecast and Analysis
7.5. LAB-ON-A-CHIP
7.5.1. Overview
7.5.2. Lab-On-A-Chip Market Forecast and Analysis
7.6. OTHER ARRAYS
7.6.1. Overview
7.6.2. Other Arrays Market Forecast and Analysis
8. BIOCHIP MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS AND DIAGNOSTICS CENTERS
8.3.1. Overview
8.3.2. Hospitals and Diagnostics Centers Market Forecast and Analysis
8.4. ACADEMIC AND RESEARCH INSTITUTES
8.4.1. Overview
8.4.2. Academic and Research Institutes Market Forecast and Analysis
8.5. BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
8.5.1. Overview
8.5.2. Biotechnology and Pharmaceutical Companies Market Forecast and Analysis
9. BIOCHIP MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Biochip Market Overview
9.1.2 North America Biochip Market Forecasts and Analysis
9.1.3 North America Biochip Market Forecasts and Analysis - By Type
9.1.4 North America Biochip Market Forecasts and Analysis - By End User
9.1.5 North America Biochip Market Forecasts and Analysis - By Countries
9.1.5.1 United States Biochip Market
9.1.5.1.1 United States Biochip Market by Type
9.1.5.1.2 United States Biochip Market by End User
9.1.5.2 Canada Biochip Market
9.1.5.2.1 Canada Biochip Market by Type
9.1.5.2.2 Canada Biochip Market by End User
9.1.5.3 Mexico Biochip Market
9.1.5.3.1 Mexico Biochip Market by Type
9.1.5.3.2 Mexico Biochip Market by End User
9.2. EUROPE
9.2.1 Europe Biochip Market Overview
9.2.2 Europe Biochip Market Forecasts and Analysis
9.2.3 Europe Biochip Market Forecasts and Analysis - By Type
9.2.4 Europe Biochip Market Forecasts and Analysis - By End User
9.2.5 Europe Biochip Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Biochip Market
9.2.5.1.1 Germany Biochip Market by Type
9.2.5.1.2 Germany Biochip Market by End User
9.2.5.2 France Biochip Market
9.2.5.2.1 France Biochip Market by Type
9.2.5.2.2 France Biochip Market by End User
9.2.5.3 Italy Biochip Market
9.2.5.3.1 Italy Biochip Market by Type
9.2.5.3.2 Italy Biochip Market by End User
9.2.5.4 Spain Biochip Market
9.2.5.4.1 Spain Biochip Market by Type
9.2.5.4.2 Spain Biochip Market by End User
9.2.5.5 United Kingdom Biochip Market
9.2.5.5.1 United Kingdom Biochip Market by Type
9.2.5.5.2 United Kingdom Biochip Market by End User
9.2.5.6 Rest of Europe Biochip Market
9.2.5.6.1 Rest of Europe Biochip Market by Type
9.2.5.6.2 Rest of Europe Biochip Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Biochip Market Overview
9.3.2 Asia-Pacific Biochip Market Forecasts and Analysis
9.3.3 Asia-Pacific Biochip Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Biochip Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Biochip Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Biochip Market
9.3.5.1.1 Australia Biochip Market by Type
9.3.5.1.2 Australia Biochip Market by End User
9.3.5.2 China Biochip Market
9.3.5.2.1 China Biochip Market by Type
9.3.5.2.2 China Biochip Market by End User
9.3.5.3 India Biochip Market
9.3.5.3.1 India Biochip Market by Type
9.3.5.3.2 India Biochip Market by End User
9.3.5.4 Japan Biochip Market
9.3.5.4.1 Japan Biochip Market by Type
9.3.5.4.2 Japan Biochip Market by End User
9.3.5.5 South Korea Biochip Market
9.3.5.5.1 South Korea Biochip Market by Type
9.3.5.5.2 South Korea Biochip Market by End User
9.3.5.6 Rest of Asia-Pacific Biochip Market
9.3.5.6.1 Rest of Asia-Pacific Biochip Market by Type
9.3.5.6.2 Rest of Asia-Pacific Biochip Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Biochip Market Overview
9.4.2 Middle East and Africa Biochip Market Forecasts and Analysis
9.4.3 Middle East and Africa Biochip Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Biochip Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Biochip Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Biochip Market
9.4.5.1.1 South Africa Biochip Market by Type
9.4.5.1.2 South Africa Biochip Market by End User
9.4.5.2 Saudi Arabia Biochip Market
9.4.5.2.1 Saudi Arabia Biochip Market by Type
9.4.5.2.2 Saudi Arabia Biochip Market by End User
9.4.5.3 U.A.E Biochip Market
9.4.5.3.1 U.A.E Biochip Market by Type
9.4.5.3.2 U.A.E Biochip Market by End User
9.4.5.4 Rest of Middle East and Africa Biochip Market
9.4.5.4.1 Rest of Middle East and Africa Biochip Market by Type
9.4.5.4.2 Rest of Middle East and Africa Biochip Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Biochip Market Overview
9.5.2 South and Central America Biochip Market Forecasts and Analysis
9.5.3 South and Central America Biochip Market Forecasts and Analysis - By Type
9.5.4 South and Central America Biochip Market Forecasts and Analysis - By End User
9.5.5 South and Central America Biochip Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Biochip Market
9.5.5.1.1 Brazil Biochip Market by Type
9.5.5.1.2 Brazil Biochip Market by End User
9.5.5.2 Argentina Biochip Market
9.5.5.2.1 Argentina Biochip Market by Type
9.5.5.2.2 Argentina Biochip Market by End User
9.5.5.3 Rest of South and Central America Biochip Market
9.5.5.3.1 Rest of South and Central America Biochip Market by Type
9.5.5.3.2 Rest of South and Central America Biochip Market by End User
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL BIOCHIP MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. BIOCHIP MARKET, KEY COMPANY PROFILES
12.1. ABBOTT LABORATORIES
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. AGILENT TECHNOLOGIES, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. PERKINELMER INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. FLUIDIGM CORPORATION
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ILLUMINA, INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. GE HEALTHCARE
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. BIO-RAD LABORATORIES INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. CEPHEID INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. THERMO FISHER SCIENTIFIC, INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. F. HOFFMANN-LA ROCHE AG
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. Abbott Laboratories
2. Agilent Technologies, Inc.
3. PerkinElmer Inc.
4. Fluidigm Corporation
5. Illumina, Inc.
6. GE Healthcare
7. Bio-Rad Laboratories Inc.
8. Cepheid Inc.
9. Thermo Fisher Scientific, Inc.
10. F. Hoffmann-La Roche AG
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For